Androjek, a global leader in diagnostics for male and animal infertility, announced today their plans to locate their corporate headquarters in the biotech incubator of the Ennovation Center in Independence, Missouri.
Androjek will be relocating their offices and lab facilities from Fort Lauderdale during the 1st quarter of 2012 and will eventually hire 18 new employees to staff their operations.
The successful recruitment was supported by the Independence EDC, City of Independence, Independence School District, Missouri Technology Corporation, Lead Capital and the Missouri Department of Economic Development. No formal press conference is planned but an open house for the company will be held once the lab is operational and the company has completed their transition from the Florida facility.
About Androjek
AndroJek provides innovative screening and diagnostics for both male human and animal infertility by offering a variety of clinically-proven, patented, specialty male fertility tests. They are a leader in novel testing for male reproductive health challenges. Their core technologies are encapsulated by the Male Reproductive HealthSM panel. The panel determines the causes, corrections, and ART treatment paths for couples experiencing male-factor infertility.
AndroJek, Inc. was formed in June 2008. At the core of AndroJek's technologies is nearly 30 years of work of Dr. David Brown, an award-winning and highly regarded molecular and reproductive biologist. Dr. Brown's research focused on enhancing the screening and diagnosis of male-factor infertility issues.
